Incidence, Predictors, and Impact of Hospital Readmission After Revascularization for Left Main Coronary Disease

医学 传统PCI 经皮冠状动脉介入治疗 入射(几何) 左主干冠状动脉疾病 冠状动脉疾病 血运重建 心脏病学 累积发病率 内科学 比例危险模型 旁路移植 冠状动脉搭桥手术 动脉 心肌梗塞 队列 光学 物理
作者
Ioanna Kosmidou,Bahira Shahim,Ovidiu Dressler,Björn Redfors,Marie‐Claude Morice,John D. Puskas,David E. Kandzari,Dimitri Karmpaliotis,W. Morris Brown,Nicholas Lembo,Adrian Banning,A. Pieter Kappetein,Patrick W. Serruys,Joseph F. Sabik,Gregg W. Stone
出处
期刊:Journal of the American College of Cardiology [Elsevier BV]
卷期号:83 (11): 1073-1081 被引量:4
标识
DOI:10.1016/j.jacc.2024.01.012
摘要

The frequency of and relationship between hospital readmissions and outcomes after revascularization for left main coronary artery disease (LMCAD) are unknown. The purpose of this study was to study the incidence, predictors, and clinical impact of readmissions following percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) for LMCAD. In the EXCEL (XIENCE Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization) trial, 1,905 patients with LMCAD were randomized to PCI vs CABG. The cumulative incidence of readmissions was analyzed with multivariable Anderson-Gill and joint frailty models to account for recurrent events and the competing risk of death. The impact of readmission on subsequent mortality within 5-year follow-up was determined in a time-adjusted Cox proportional hazards model. Within 5 years, 1,868 readmissions occurred in 851 of 1,882 (45.2%) hospital survivors (2.2 ± 1.9 per patient with readmission[s], range 1-16), approximately one-half for cardiovascular causes and one-half for noncardiovascular causes (927 [49.6%] and 941 [50.4%], respectively). One or more readmissions occurred in 463 of 942 (48.6%) PCI patients vs 388 of 940 (41.8%) CABG patients (P = 0.003). After multivariable adjustment, PCI remained an independent predictor of readmission (adjusted HR: 1.22; 95% CI: 1.10-1.35; P < 0.0001), along with female sex, comorbidities, and the extent of CAD. Readmission was independently associated with subsequent all-cause death, with interaction testing indicating a higher risk after PCI than CABG (adjusted HR: 5.72; 95% CI: 3.42-9.55 vs adjusted HR: 2.72; 95% CI: 1.64-4.88, respectively; Pint = 0.03). In the EXCEL trial, readmissions during 5-year follow-up after revascularization for LMCAD were common and more frequent after PCI than CABG. Readmissions were associated with an increased risk of all-cause death, more so after PCI than with CABG.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
111完成签到,获得积分10
刚刚
量子星尘发布了新的文献求助10
2秒前
2秒前
不想再哭发布了新的文献求助10
2秒前
CheeseD发布了新的文献求助10
2秒前
故渊完成签到,获得积分10
2秒前
2秒前
3秒前
3秒前
张爽发布了新的文献求助20
4秒前
故渊发布了新的文献求助10
6秒前
啊嘞嘞发布了新的文献求助10
7秒前
Amy发布了新的文献求助10
8秒前
9秒前
9秒前
10秒前
张献忠发布了新的文献求助10
10秒前
10秒前
325715完成签到,获得积分10
11秒前
学术妲己完成签到,获得积分10
11秒前
李亚楠完成签到,获得积分10
12秒前
ZZY关闭了ZZY文献求助
12秒前
AG杰完成签到 ,获得积分20
13秒前
量子星尘发布了新的文献求助10
15秒前
工艺员发布了新的文献求助10
15秒前
Amy完成签到,获得积分10
16秒前
gww发布了新的文献求助10
17秒前
张献忠完成签到,获得积分10
17秒前
18秒前
18秒前
18秒前
18秒前
19秒前
CipherSage应助zerovb3采纳,获得10
19秒前
解语花发布了新的文献求助50
22秒前
22秒前
22秒前
健壮问枫发布了新的文献求助30
23秒前
23秒前
24秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Manipulating the Mouse Embryo: A Laboratory Manual, Fourth Edition 1000
计划经济时代的工厂管理与工人状况(1949-1966)——以郑州市国营工厂为例 500
Comparison of spinal anesthesia and general anesthesia in total hip and total knee arthroplasty: a meta-analysis and systematic review 500
INQUIRY-BASED PEDAGOGY TO SUPPORT STEM LEARNING AND 21ST CENTURY SKILLS: PREPARING NEW TEACHERS TO IMPLEMENT PROJECT AND PROBLEM-BASED LEARNING 500
Modern Britain, 1750 to the Present (第2版) 300
Writing to the Rhythm of Labor Cultural Politics of the Chinese Revolution, 1942–1976 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 物理化学 基因 催化作用 遗传学 冶金 电极 光电子学
热门帖子
关注 科研通微信公众号,转发送积分 4590231
求助须知:如何正确求助?哪些是违规求助? 4005083
关于积分的说明 12400271
捐赠科研通 3682147
什么是DOI,文献DOI怎么找? 2029449
邀请新用户注册赠送积分活动 1063022
科研通“疑难数据库(出版商)”最低求助积分说明 948604